Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites.
about
Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protectionPeripartum cardiomyopathy: challenges in diagnosis and management.Silent disease progression in clinically stable heart failure.Relaxin stimulates multiple signaling pathways: activation of cAMP, PI3K, and PKCzeta in THP-1 cells.Relaxin regulates MMP expression and promotes satellite cell mobilization during muscle healing in both young and aged mice.Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1.Serelaxin-mediated signal transduction in human vascular cells: bell-shaped concentration-response curves reflect differential coupling to G proteinsAngiogenic growth factors are new and essential players in the sustained relaxin vasodilatory pathway in rodents and humansRelaxin enhances the oncogenic potential of human thyroid carcinoma cells.International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.Re-modelling 'hostile' milieu of diseased myocardium via paracrine function of transplanted cells or relaxin.Relaxin increases human endothelial progenitor cell NO and migration and vasculogenesis in miceConstitutive formation of an RXFP1-signalosome: a novel paradigm in GPCR function and regulation.Basic progress and future therapeutic perspectives of relaxin in ischemic heart disease.Cellular retrograde cardiomyoplasty and relaxin therapy for postischemic myocardial repair in a rat modelHeterogeneity of the afferent arteriole--correlations between morphology and function.Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study.Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for allergic airways disease.Relaxin treatment reverses insulin resistance in mice fed a high-fat dietRelaxin improves multiple markers of wound healing and ameliorates the disturbed healing pattern of genetically diabetic mice.Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein.Relaxin: a missing link in the pathomechanisms of Systemic Lupus Erythematosus?Recombinant human relaxin-2: (how) can a pregnancy hormone save lives in acute heart failure?Relaxin: a novel agent for the treatment of acute heart failure.Serelaxin for the treatment of heart failure.Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1.Anti-fibrotic actions of relaxin.The Role of Relaxin in Normal and Abnormal Uterine Function During the Menstrual Cycle and Early Pregnancy.Relaxin' the Heart: A Novel Therapeutic Modality.Relaxin pretreatment decreases infarct size in male rats after middle cerebral artery occlusion.Paracrine effects of transplanted myoblasts and relaxin on post-infarction heart remodelling.Angiogenesis for the treatment of inoperable coronary disease: the future.Relaxin stimulates leukocyte adhesion and migration through a relaxin receptor LGR7-dependent mechanism.Relaxin induces matrix metalloproteinase-9 through activation of nuclear factor kappa B in human THP-1 cells.Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future PerspectivesRLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance.Functional and histopathological improvement of the post-infarcted rat heart upon myoblast cell grafting and relaxin therapy.Relaxin activates the MAP kinase pathway in human endometrial stromal cells.Effects of relaxin in a model of rat adjuvant-induced arthritis.
P2860
Q26740185-81B27296-6B22-4F50-BE0E-0CBD1189EB08Q33363307-0F014D35-B239-4AEA-9E1C-3744D410CDD6Q33578212-E5234AD3-FD63-4DA1-A501-FFA42BF0C147Q33757389-BE8E49A1-FF10-4E2D-BEB9-B3927D0F34D5Q34254473-1E71638A-7963-4755-BA05-52A3C5E8E7C3Q34398874-7DD0383D-B3B9-4C13-A250-A841C9DFDE45Q34771756-381DD212-6322-415C-B987-3D65263C9C85Q35039209-0B7A16D7-5C03-473A-9551-EED34D2026BAQ35042471-3B82BF28-1423-475E-BD8F-F4900B3FA7A0Q35221931-39855F32-119D-47FA-8B0F-869AF74A4A2EQ35383835-5690C06D-2B95-4474-A3E9-ED37DB6E1211Q35459559-472EE58E-4A2E-4CED-9631-A50766F683E9Q35669250-D390829E-5900-46DA-8942-67D02C35D078Q36025314-96B26E58-A70C-4911-8333-BB533BE2417BQ36163310-1DDD9015-55F0-4A9B-B587-058A56C89000Q36176574-6A1458C0-C222-41AA-A711-3F770DB6C2E8Q36541230-C1475A53-9A88-42B5-8737-ED12E0722F14Q36853140-C076A4D6-D1A6-4B77-AB22-72FB7BC38BD9Q36941251-A5A428D2-5F81-4FBC-81C9-A1442F1DDAA4Q37110579-B28C67A3-0493-410B-9D1B-2E334EE73493Q37532442-1A7BF0D4-2C04-4F64-936D-FE1067790493Q38080804-7CFC4312-0EAB-4108-9892-A4EE32E1EBFDQ38164123-DC52121D-8B19-4493-841E-A79F474227BFQ38220684-EF28E9A3-37A3-4798-8189-F73CB04EB6C5Q38373223-83354F02-C392-44B5-9DCF-2107F5A7C718Q38798476-6F33F41D-EDDA-4218-AD75-A15A47BCD40DQ38807047-793503AD-0DCB-4E3F-897C-E7876059353DQ38850557-B83A8373-7DD2-4844-9D51-DD6C96D02DEFQ38882840-F9CC6A2F-FEA4-4244-A379-5F663523F803Q38940630-C65A24A0-CDCF-451E-BA95-D8F76D75B8ABQ39720492-DE599107-E95D-4AEB-951B-0D22BBEC8FB9Q39740814-534DC749-A7BE-49F5-8274-81E7D5104FD6Q40290272-5776E929-B1D0-4402-9C84-EB1E6EAD8C52Q40348456-D7FE961A-EED4-4358-90A6-13EB8E9C2DFDQ40409503-6E338194-2DEB-49B3-B517-317ABA74F2EFQ41463324-AE306C1B-8FEE-4052-89CE-351C2C7F401CQ41682526-D08088A8-3F21-43DE-9473-99C7DAA92257Q42079587-99531ABF-40EF-4034-B0AA-A90C4F1F8B9BQ46078497-580918C1-6697-457E-B238-7A42C4F61255Q46547394-9B7A90E5-4C91-4F73-864B-04B34C30BC3E
P2860
Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Relaxin induces vascular endot ...... is selectively at wound sites.
@en
type
label
Relaxin induces vascular endot ...... is selectively at wound sites.
@en
prefLabel
Relaxin induces vascular endot ...... is selectively at wound sites.
@en
P2093
P1476
Relaxin induces vascular endot ...... is selectively at wound sites.
@en
P2093
Constant J
Deshpande U
Erikson ME
Pickford LB
P304
P356
10.1111/J.1524-475X.2000.00361.X
P577
2000-09-01T00:00:00Z